Category: TB-500

  • TB-500 UK: The Ultimate Buyer’s Guide (Purity, COA & Prices 2026)

    TB-500 UK: The Ultimate Buyer’s Guide (Purity, COA & Prices 2026)

    TB-500 is the recovery world’s other favourite peptide — the compound urologist Dr Alex Tatem called BPC-157’s “brother” in his viral Diary of a CEO interview. If you’re looking to buy TB-500 in the UK, this is the version that respects your intelligence: what it genuinely is (including a labelling nuance most sellers quietly skip), what the research does and doesn’t show, what a fair price looks like, and the one document that separates a real supplier from a confident stranger with a vial. To step back and look at the broader science of what do peptides do, check our UK guide. Research use only, throughout.

    Key takeaways

    • TB-500 is a synthetic peptide based on thymosin beta-4 (Tβ4), studied in tissue-repair, blood-flow and recovery research.
    • A genuine label nuance: some “TB-500” is the active fragment, some is full-length Tβ4 — the COA tells you which.
    • In the UK it’s sold strictly as a research chemical for laboratory use only, with no MHRA authorisation.
    • It’s the classic partner to BPC-157 — the basis of the Wolverine Stack — and on the FDA’s 2026 reconsideration list.
    • Expect 5mg vials roughly £20–£40. The batch COA, not the price, is what proves quality.

    What is TB-500?

    TB-500 is a synthetic peptide derived from thymosin beta-4, a naturally occurring protein involved in cell migration, blood-vessel formation (angiogenesis) and tissue repair. Its best-studied trick is binding actin — part of how cells move to a site of injury and rebuild. That repair-and-recovery profile is exactly why it’s so often mentioned alongside BPC-157.

    Specs a serious supplier should hand over without hesitation:

    PropertyValue
    Based onThymosin beta-4 (Tβ4)
    Common research strength2mg, 5mg vials
    AppearanceWhite to off-white lyophilised (freeze-dried) powder
    Typical research purity≥99% (stated on the COA, not just the label)
    Identity checkMass spectrometry confirming the expected molecular weight

    The label nuance most sellers skip

    Here’s the bit that separates an informed buyer from the rest. “TB-500” is used loosely across the market: sometimes it refers to a short active fragment of thymosin beta-4, and sometimes to the full-length Tβ4 protein. They are related but not identical, and the molecular weights differ — which is precisely why the mass-spec section of a batch COA matters. If a vendor can’t tell you which one is in the vial, they don’t really know what they’re selling.

    What Dr Alex Tatem said about TB-500

    In his 90-minute peptide explainer (2.6 million views), Dr Tatem introduced TB-500 as the sibling to BPC-157, describing it as improving blood flow to an injured area: “you could think of this as sending the soldiers, as sending the cells that are required for rebuilding that tissue matrix that was damaged by a tear or a cut.” He also listed it among the seven peptides the FDA signalled it would reconsider for legal compounding in 2026. You can watch the full interview here, and our full breakdown of it is here.

    What the research actually shows

    As with its brother peptide, the honest summary is: the interesting work is largely preclinical. Thymosin beta-4 and TB-500 have been studied in animal and cell models for wound healing, cardiac tissue and tendon/ligament repair, with mechanisms around actin regulation and angiogenesis. Controlled human efficacy data are limited. That makes it a legitimate research compound — not a proven human treatment, and no honest UK supplier should pretend otherwise. One more bit of context worth knowing: like BPC-157, TB-500 is on the WADA Prohibited List, so it’s banned in competitive sport.

    TB-500 vs BPC-157: how they differ

     TB-500BPC-157
    Derived fromThymosin beta-4A gastric-juice sequence (Body Protection Compound)
    Signature mechanismActin binding, cell migration, blood flowAngiogenesis at injury sites, gut-lining repair
    Research focusSystemic recovery, tissue and tendon repairLocalised tissue, tendon and gut research
    Usually researched withBPC-157TB-500
    VerificationBatch COA, ≥99%, mass-spec IDBatch COA, ≥99%, mass-spec ID

    They’re distinct compounds, frequently studied together — never interchangeable. For the BPC-157 side in full, see our BPC-157 UK buyer’s guide.

    Is TB-500 legal in the UK?

    TB-500 is not a controlled drug in the UK, but it has no MHRA marketing authorisation — so it can only be sold as a research chemical for laboratory use, not for human consumption. The FDA’s 2026 move to reconsider it is a US regulatory development; it doesn’t change the UK position. A supplier attaching dosing or health claims to TB-500 has stepped outside that line — and casual compliance usually travels with casual quality control.

    The quality problem — and the fix

    Dr Tatem’s sharpest warning applies squarely here: buying unverified peptides from the grey market is, in his words, like “getting gas station sushi… because there isn’t any quality control.” Lyophilised powder is the perfect disguise — you can’t see purity, dose or even identity. The only real defence is a batch-specific, third-party Certificate of Analysis confirming ≥99% purity by HPLC and identity by mass spectrometry, matched to the lot number on your vial. See how we document it on our COA process and quality testing pages, and our standalone guide to reading a peptide COA.

    TB-500 UK price: what to expect

    In the UK, TB-500 5mg vials typically advertise from around £20 to £40, with bulk pricing reducing the per-vial cost. Judge value by cost per verified milligram, not the sticker: a cheap vial that skips testing — or that’s actually a different molecular weight than claimed — isn’t a saving, it’s a gamble. The same logic from our value breakdown applies here.

    What good looks like: the buyer’s checklist

    CheckWhat good looks likeRed flag
    COABatch-specific, third-party (e.g. Janoshik), verifiableGeneric image, no batch number
    Purity≥99% by HPLC, on the certificate“High purity” with no figure
    IdentityMass spec confirms which Tβ4 form it isNo mass-spec data at all
    FormLyophilised powder, sealed vialPre-mixed liquid of unknown age
    Labelling“Research use only / not for human consumption”Dosing or health claims
    DispatchUK-based, trackedVague origin, no tracking

    TB-500 in research blends

    TB-500 rarely works alone in recovery research. It’s paired with BPC-157 in the Wolverine Stack (BPC-157 + TB-500), and joins BPC-157 and the copper peptide GHK-Cu in the triple-peptide Klikglow 70mg — which we dissect in our Klikglow pharmacological analysis. The rule for any blend: a single COA stapled to a three-peptide product is two certificates short — every component needs its own verification.

    Where MyReta fits

    We supply TB-500 and related research peptides in the UK as lab-tested, research-use-only compounds — each with a batch-specific third-party COA and verified purity, dispatched from the UK. Browse current stock in our shop, and for the universal checks on vetting any supplier, see our guide to buying research peptides in the UK.

    Frequently asked questions

    Is TB-500 legal in the UK?

    It is not a controlled drug, but it has no MHRA authorisation, so it can only be sold as a research chemical for laboratory use, not for human consumption. It’s also banned in competitive sport under the WADA Prohibited List.

    What is the difference between TB-500 and thymosin beta-4?

    TB-500 is derived from thymosin beta-4. Some products are a short active fragment, others are full-length Tβ4 — the molecular weights differ, so the mass-spec section of the COA tells you exactly which you have.

    What is the difference between TB-500 and BPC-157?

    They are distinct peptides — TB-500 from thymosin beta-4, BPC-157 from a gastric sequence — but both are studied in recovery research and frequently together, which is why blends like the Wolverine Stack pair them.

    How do I know if my TB-500 is real?

    Insist on a batch-specific, third-party COA confirming ≥99% purity by HPLC and identity by mass spectrometry, matched to your vial’s lot number. Without it, you can’t verify it.

    How much does TB-500 cost in the UK?

    5mg vials typically advertise from around £20–£40, with bulk pricing lowering the per-vial cost. Judge by cost per verified milligram, not the headline price.

    The bottom line

    Buying TB-500 in the UK follows the same discipline as its brother peptide: demand the batch COA, confirm ≥99% purity and which Tβ4 form you’re getting, ignore the suspiciously cheap, and buy from an accountable UK supplier. Browse lab-tested stock in our shop, and pair this with our BPC-157 guide if you’re researching the two together.

    This article is for informational and research purposes only. TB-500 is supplied for laboratory research use only and is not for human consumption. It has no MHRA marketing authorisation. Nothing here is medical advice.

  • Wolverine Stack: The Science and Truth Behind BPC-157 and TB-500

    Wolverine Stack: The Science and Truth Behind BPC-157 and TB-500

    Wolverine Stack 40mg: The Science and Truth Behind BPC-157 and TB-500

    If you have spent any time in the biohacking, fitness, or longevity communities, you’ve likely heard the name: The Wolverine Stack.

    It sounds like something out of a comic book—a way to achieve rapid, regenerative healing. But beneath the hype lies a fascinating piece of biochemistry. Today, we are stripping away the “bro-science” to look at the actual published literature regarding the Wolverine Stack 40mg, focusing on the potent synergy between BPC-157 and TB-500.

    Watch the full deep-dive video here

    What is the Wolverine Stack?

    The “Wolverine Stack” is a term used to describe a combination of two specific peptides: BPC-157 and TB-500.

    While many people use them in isolation, the “stack” approach is based on a highly logical biological rationale: Synergy.

    To understand why this combination is so effective, we have to look at the individual roles of each component.

    BPC-157: Building the “Roads” for Healing

    BPC-157 (Body Protection Compound-157) is a synthetic peptide that acts as a master regulator of the healing environment. Biochemically, BPC-157 focuses on Angiogenesis—the process of creating new blood vessels.

    It works through several key pathways, most notably the VEGFA and ERK1/2 signaling cascades.

    • Angiogenesis: It upregulates the VEGFA pathway, triggering the growth of new blood vessels to bring nutrients to injured sites.
    • Nitric Oxide Production: It activates the eNOS pathway, improving blood flow and vasodilation.
    • Cell Survival: It enhances the FAK/paxillin pathway, helping cells survive and migrate under oxidative stress.

    In simple terms, BPC-157 builds the “roads” to the injury. By increasing blood flow, it ensures that oxygen and essential nutrients can actually reach the damaged tissue.

    TB-500: Sending in the “Workers”

    TB-500 (a synthetic analog of Thymosin Beta-4) focuses on the machinery: the cells themselves. TB-500’s primary job is regulating Actin, the structural protein that allows your cells to move and change shape.

    By regulating actin dynamics, TB-500 facilitates cell migration. If BPC-157 builds the roads, TB-500 is the construction crew—it enables the cells to physically move into the wound site to begin the repair process.

    The Synergy: Why the Wolverine Stack 40mg Works

    The reason the Wolverine Stack 40mg is such a staple in regenerative protocols is the intersection of these two processes. To heal a tissue, you need both a delivery system (blood flow) and a construction crew (cellular movement).

    BPC-157 builds the roads, while TB-500 sends in the workers. Together, they provide a comprehensive approach to tissue remodeling.

    The Patent Paradox: Why isn’t this FDA-Approved?

    A common question is: Why isn’t this FDA-Approved? The answer isn’t found in the science, but in Law.

    In the landmark case Association for Molecular Pathology v. Myriad Genetics (2013), the U.S. Supreme Court ruled unanimously that naturally occurring human genes are not patent-eligible. The decision determined that isolating a gene from a patient’s body does not make it a patentable invention, while synthetic complementary DNA (cDNA) remains patent-eligible (Read the full legal case on Justia).

    Because BPC-157 and TB-500 are derived from natural proteins, pharmaceutical companies cannot secure the patent exclusivity required to recoup the billions of dollars needed for clinical trials. This leaves these compounds in a “regulatory limbo” commonly used in the research and biohacking community.

    Safety and Sourcing Matters

    Because these peptides are often sourced through the “gray market,” purity is your biggest concern. Research has shown that unregulated products can vary wildly in purity.

    When looking for high-quality peptides, always prioritize:

    • Third-party testing (COAs).
    • Verification of amino acid sequences.
    • Absence of heavy metals and endotoxins.

    Shop the Premium Wolverine Stack 40mg here


    Further Reading:
    Comprehensive Pharmacological Analysis of Multi-Peptide Complexes